Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Reines

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Progress in Clinical and Biological Research|January 1, 1989
Early clinical trials in Alzheimer's disease: selection and evaluation of drug candidatesS A Reines
Nucleic Acids Research|June 1, 1974
New fluorescent hydrazide reagents for the oxidized 3'-terminus of RNAS A Reines, C R Cantor
Methods in Enzymology|January 1, 1979
A new method for attachment of fluorescent probes to tRNAS A Reines, L H Schulman
Nucleic Acids Research|March 11, 1981
Attachment of protein affinity-labeling reagents of variable length and amino acid specificity to E. coli tRNAfMetL H Schulman, H Pelka, S A Reines
Biopolymers|October 1, 1977
Pyrene derivatives as fluorescent probes of conformation near the 3' termini of polyribonucleotidesP Koenig, S A Reines, C R Cantor
Journal of Molecular Biology|October 5, 1974
Investigation of the ribosomal peptidyl transferase center using a photoaffinity labelN Hsiung, S A Reines, C R Cantor
Archives of General Psychiatry|June 1, 1997
The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist GroupM S Kramer, B Last, A Getson, et al.
JAMA|November 9, 1984
Migraine prevention with timolol. A double-blind crossover studyS Stellar, S P Ahrens, A R Meibohm, et al.
Anxiety|January 1, 1994
Pilot study of a CCKB antagonist in patients with panic disorder: preliminary findingsJ J Sramek, M S Kramer, S A Reines, et al.
Headache|April 4, 2001
Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study GroupsG A Block, J Goldstein, A Polis, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Progress in Clinical and Biological Research|January 1, 1989
Early clinical trials in Alzheimer's disease: selection and evaluation of drug candidatesS A Reines
Nucleic Acids Research|June 1, 1974
New fluorescent hydrazide reagents for the oxidized 3'-terminus of RNAS A Reines, C R Cantor
Methods in Enzymology|January 1, 1979
A new method for attachment of fluorescent probes to tRNAS A Reines, L H Schulman
Nucleic Acids Research|March 11, 1981
Attachment of protein affinity-labeling reagents of variable length and amino acid specificity to E. coli tRNAfMetL H Schulman, H Pelka, S A Reines
Biopolymers|October 1, 1977
Pyrene derivatives as fluorescent probes of conformation near the 3' termini of polyribonucleotidesP Koenig, S A Reines, C R Cantor
Journal of Molecular Biology|October 5, 1974
Investigation of the ribosomal peptidyl transferase center using a photoaffinity labelN Hsiung, S A Reines, C R Cantor
Archives of General Psychiatry|June 1, 1997
The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist GroupM S Kramer, B Last, A Getson, et al.
JAMA|November 9, 1984
Migraine prevention with timolol. A double-blind crossover studyS Stellar, S P Ahrens, A R Meibohm, et al.
Anxiety|January 1, 1994
Pilot study of a CCKB antagonist in patients with panic disorder: preliminary findingsJ J Sramek, M S Kramer, S A Reines, et al.
Headache|April 4, 2001
Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study GroupsG A Block, J Goldstein, A Polis, et al.
Pageof 3